As Vice President of Information Technology at Mural Oncology, Thomas Skoff plays a pivotal role in shaping the technological landscape of the organization. With over 30 years of experience in the biotechnology sector, he brings a wealth of expertise in IT executive management and strategic...
As Vice President of Information Technology at Mural Oncology, Thomas Skoff plays a pivotal role in shaping the technological landscape of the organization. With over 30 years of experience in the biotechnology sector, he brings a wealth of expertise in IT executive management and strategic planning. Thomas successfully led the critical IT separation process from Alkermes, ensuring a seamless transition and the establishment of robust IT services for the newly formed Mural Oncology. This foundational work not only laid the groundwork for operational efficiency but also positioned the company to leverage technology in support of its strategic business initiatives.
In his current role, Thomas is responsible for developing and executing a comprehensive IT strategy and roadmap that aligns with Mural Oncology’s business functions. His leadership is instrumental in fostering cross-functional collaboration, ensuring that IT integration is not just a technical endeavor but a strategic enabler across the organization. He oversees all IT services, focusing on process improvement and vendor management to optimize performance and drive innovation. His ability to communicate effectively and lead diverse teams has been critical in navigating the complexities of the pharmaceutical industry, where agility and responsiveness to market changes are paramount.
Thomas's commitment to enhancing IT capabilities is evident in his approach to project management and CRM systems, which are tailored to meet the unique needs of Mural Oncology. By harnessing cutting-edge technology and fostering a culture of continuous improvement, he is dedicated to advancing the company’s mission of delivering transformative therapies to patients. His insights and leadership are invaluable assets as Mural Oncology continues to evolve in a competitive landscape.
